Advances in Glycobiotechnology

Artikelnummer: 978-3-030-69589-7
Einband: Fester Einband
Verfügbarkeit: Folgt in ca. 10 Arbeitstagen
CHF 392.00
decrease increase

Outlines recombinant glycoprotein expression in different host systems Discusses the role of glycosylation on protein function and vaccine development Updates on cutting edge glycoanalytical technologies Sets out future directions in glycobiotechnology and glycoanalysis

Outlines recombinant glycoprotein expression in different host systems Discusses the role of glycosylation on protein function and vaccine development Updates on cutting edge glycoanalytical technologies Sets out future directions in glycobiotechnology and glycoanalysis

Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagSpringer
EinbandFester Einband
Erscheinungsjahr2021
Seitenangabe472 S.
AusgabekennzeichenEnglisch
MasseH24.1 cm x B16.0 cm x D3.1 cm 818 g
Auflage21001 A. 1st edition 2021
AutorRapp, Erdmann (Hrsg.) / Reichl, Udo (Hrsg.)

Über den Autor Erdmann (Hrsg.) Rapp

Dr. Erdmann Rapp is heading the Bio/Process Analytics team of the Bioprocess Engineering Department at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and founder, CEO & CSO of glyXera, providing tailored cutting-edge glycoanalytical products and services. He is an experienced researcher, inventor, mentor and university lecturer. He and his team are working on the development and implementation of innovative bio/process analytics - in particular, on sophisticated tools for proteomics, glycoproteomics and glycomics - for a deeper understanding of biological and biotechnological processes. Dr. Rapp's successful research is documented by more than 120 peer-reviewed papers and book chapters, and 8 patents.Professor Udo Reichl is a Scientific Member of the Max Planck Society, Director of the Bioprocess Engineering Department of the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and Chair of Bioprocess Engineering at the Otto-von-Guericke University Magdeburg. He has profound expertise in the development and optimization of cell culture-based viral vaccine production. His group developed sophisticated analytical tools to monitor process dynamics, metabolism of cell lines, infection dynamics and the glycosylation of viral and recombinant proteins. His list of publications comprises more than 250 peer-reviewed papers and book chapters, and he has filed various patents.

Weitere Titel von Erdmann (Hrsg.) Rapp

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten